MY SIZE INC (MYSZ)

US62844N3070 - Common Stock

3.8901  -0.26 (-6.26%)

After market: 3.92 +0.03 (+0.77%)

Fundamental Rating

1

Taking everything into account, MYSZ scores 1 out of 10 in our fundamental rating. MYSZ was compared to 276 industry peers in the Software industry. Both the profitability and financial health of MYSZ have multiple concerns. While showing a medium growth rate, MYSZ is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

MYSZ had negative earnings in the past year.
MYSZ had a negative operating cash flow in the past year.
MYSZ had negative earnings in each of the past 5 years.
MYSZ had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

MYSZ has a Return On Assets of -70.90%. This is amonst the worse of the industry: MYSZ underperforms 85.77% of its industry peers.
With a Return On Equity value of -134.64%, MYSZ is not doing good in the industry: 75.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -70.9%
ROE -134.64%
ROIC N/A
ROA(3y)-80.04%
ROA(5y)-119.7%
ROE(3y)-138.22%
ROE(5y)-246.92%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MYSZ has a worse Gross Margin (39.01%) than 74.45% of its industry peers.
In the last couple of years the Gross Margin of MYSZ has declined.
The Profit Margin and Operating Margin are not available for MYSZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.92%
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYSZ has more shares outstanding
MYSZ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MYSZ has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -8.88, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MYSZ (-8.88) is worse than 88.69% of its industry peers.
MYSZ has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MYSZ (0.09) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -8.88
ROIC/WACCN/A
WACC8.78%

2.3 Liquidity

A Current Ratio of 1.71 indicates that MYSZ should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.71, MYSZ is in line with its industry, outperforming 50.00% of the companies in the same industry.
MYSZ has a Quick Ratio of 1.71. This is a bad value and indicates that MYSZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MYSZ has a worse Quick ratio (0.97) than 76.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.97

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.63% over the past year.
Looking at the last year, MYSZ shows a very strong growth in Revenue. The Revenue has grown by 56.86%.
MYSZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 268.33% yearly.
EPS 1Y (TTM)59.63%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q76.34%
Revenue 1Y (TTM)56.86%
Revenue growth 3Y268.33%
Revenue growth 5YN/A
Revenue growth Q2Q11.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y63.47%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year36.36%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYSZ. In the last year negative earnings were reported.
Also next year MYSZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MYSZ!.
Industry RankSector Rank
Dividend Yield N/A

MY SIZE INC

NASDAQ:MYSZ (4/24/2024, 7:18:38 PM)

After market: 3.92 +0.03 (+0.77%)

3.8901

-0.26 (-6.26%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.15M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -70.9%
ROE -134.64%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 39.01%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.71
Quick Ratio 0.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)59.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y63.47%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)56.86%
Revenue growth 3Y268.33%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y